Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for TAMIFLU
- Xofluza-Wearables Feasibility-Study
- ADaptive ASsessment of TReatments for influenzA: A Phase 2 Platform Trial of Antiviral Pharmacodynamics in Early Symptomatic Influenza
- Effects of Nasal-spraying LiveSpo Navax in Treatment of Influenza Virus in Children
- Study on the Human Bioequivalence of Oseltamivir Phosphate For Oral Suspension
- Baloxavir in Combination With Oseltamivir in Allogenic Bone Marrow Transplant Recipients With Influenza
- Bioavailability of Oseltamivir Phosphate 75 mg With Regards to Reference Product
- Open-label Study of Neuraminidase Inhibitor Treatment in STEMI Patients
- Bioequivalence Study of Oseltamivir Phosphate and TAMIFLU Under Fed Condition in Healthy Volunteers
- Catalysing the Containment of COVID-19
- Study to Evaluate the Efficacy and Safety of IV VIS410 Plus Oseltamivir Versus Oseltamivir Alone in Hospitalized Adults With Influenza A Infection Requiring Oxygen Support
- Dose Ranging Study to Evaluate the Efficacy and Safety of MEDI8852 in Adults Who Are Hospitalized With Type A Influenza.
- A Pharmacokinetics, Pharmacodynamics and Safety Study of Warfarin in Combination With Tamiflu (Oseltamivir)
- A Study to Investigate the Safety, Tolerability, and Pharmacokinetics (PK) of Oseltamivir and Its Carboxylate Metabolite, RO0640802 in Healthy Participants
- Lingdancao Granules in the Treatment of Seasonal Influenza
- A Pilot Study of the Safety, Tolerability, and Effectiveness of Halo
- A Multiple-Dose Study of Oral Oseltamivir in Participants on Hemodialysis (HD) and Continuous Ambulatory Peritoneal Dialysis (CAPD)
- ED Influenza Therapeutic Pilot Study: Oseltamivir vs. Peramivir
- A Trial of Oseltamivir in High-Risk Patients Presenting to the Emergency Department With Influenza
- A Bioequivalence Study of Oseltamivir From Oseltamivir 75 mg Caps (Pharmacare PLC, Palestine) and Tamiflu® 75 mg Caps (Hoffmann-La Roche, Switzerland)
- A Study of MHAA4549A in Combination With Oseltamivir Versus Oseltamivir in Participants With Severe Influenza A Infection
- An RCT of Oseltamivir in Outpatients With CPD: A Pilot Study.
- A Study to Assess the Drug-Drug Interaction Between VX-787 and Oseltamivir
- Treatment of Severe Influenza A Infection
- A Study of MHAA4549A in Healthy Volunteers in an Influenza Challenge Model
- A Clinical Trial to Investigate the Influence of CES1 Polymorphism on Oseltamivir
- Comparative Clinical Trial of Efficacy and Safety of Ergoferon Versus Oseltamivir in Treatment of Influenza
- Clinical Trial of Clinical Efficiency and Safety of Ergoferon in Treatment of Influenza
- A Pharmacokinetic/Pharmacodynamic Study of Oseltamivir in Immunocompromised Children With Confirmed Influenza Infection
- Alcohol Inhibits Drug Metabolism by Carboxylesterases
- Panama and El Salvador Children's Oseltamivir Study
- Safety and Efficacy Study of Nitazoxanide in the Treatment of Acute Uncomplicated Influenza
- A Single Dose Study of Tamiflu in Volunteers in Dialysis And in Volunteers With Reduced Creatinine Clearance
- Oseltamivir for Influenza Lower Respiratory Tract Infection in Children Under One
- Time to Oseltamivir Access When Prescribed by Pharmacists Versus Physicians (ACCESS)
- Characterisation of the Human Carboxylesterase 1 (CES1) Mutations in Thailand
- Effect of Oseltamivir on Cognitive Function in Subjects With Influenza
- Rapid Empiric Treatment With Oseltamivir Study (RETOS)
- A Study of Intravenous Zanamivir Versus Oral Oseltamivir in Adults and Adolescents Hospitalized With Influenza
- Comparing the Efficacy, Safety, and Tolerability of Combination Antivirals (Amantadine, Ribavirin, Oseltamivir) Versus Oseltamivir for the Treatment of Influenza in Adults at Risk for Complications
- Pharmacokinetics of Oseltamivir Carboxylate In Morbidly Obese Subjects
- A Pharmacokinetic Study on Co-administration of Tamiflu (Oseltamivir) and Rimantadine in Healthy Volunteers
- Interferon Alpha Lozenges Plus Oseltamivir for Influenza Treatment
- Observational Study on the Pharmacokinetics of Oseltamivir in the Treatment of Influenza During Lactation
- A Study of Intravenous Oseltamivir [Tamiflu] in Infants With Influenza
- A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza
- Safety and Efficacy of Oseltamivir in Children Younger Than One Year of Age
- A Study of Intravenous Tamiflu (Oseltamivir) in Children With Influenza
- A Study of Tamiflu (Oseltamivir) for Treatment of Influenza With a Focus on (H1N1) 2009 Flu Strain
- Trial Comparing High Versus Standard Dose Oseltamivir in Severe Influenza Infection in ICU
- A Pharmacokinetic/Pharmacodynamic (PK/PD) and Safety Evaluation of Oseltamivir [Tamiflu] in the Treatment of Infants 0 to <12 Months of Age With Confirmed Flu Infection
- Long Term Influenza Prophylaxis With Inhaled Zanamivir or Oral Oseltamivir
- A Clinical Trial Comparing Oseltamivir With Placebo And Zanamivir With Control As First Line Treatment For Human Swine Influenza Infection
- Oral Triple Combination Antiviral Drug Therapy for Treatment of Influenza A in Immunocompromised Subjects
- A Study on Emergence of Resistance With Oseltamivir (Tamiflu) in Participants With Seasonal Influenza
- Chinese Medicinal Herbs Treatment on Novel Influenza A (H1N1)Pneumonia: Multi-centre, Prospective, Randomized Controlled Study
- Pharmacokinetic Study of Oseltamivir and Intravenous Zanamivir in Healthy Adults
- Influenza Resistance Information Study
- A Study of the Pharmacology of Oseltamivir (Tamiflu) in Pregnancy
- TCAD vs. Monotherapy for Influenza A in Immunocompromised Patients
- Study of the Relative Oral Bioavailability of the Antiflu Medicine Oseltamivir in the Intensive Care Unit
- Oseltamivir Randomised Controlled Efficacy Trial
- Early Oseltamivir Treatment of Influenza in Children 1-3 Years of Age
- Efficacy Study of Early Versus Late Oseltamivir Administration for Treating and Preventing Influenza
- A Study of Oseltamivir (Tamiflu) for Treatment of Influenza in Immunocompromised Participants.
- A Study of Tamiflu (Oseltamivir) Treatment in Laboratory-Confirmed Influenza.
- A Study of Oseltamivir (Tamiflu) for the Seasonal Prophylaxis of Influenza in Immunocompromised Participants
- A Study of Tamiflu (Oseltamivir) for Seasonal Prophylaxis of Influenza in Children.
- Oseltamivir Treatment for Children Less Than 24 Months of Age With Influenza
- Alternative Oseltamivir Dosing Strategies
- Evaluation of Alternative Oseltamivir (Tamiflu) Dosing Strategies.
- High-Dose Versus Standard-Dose Oseltamivir to Treat Severe Influenza and Avian Influenza
Clinical trials list
click for details